Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2012-02-21
Product name
MultiTrap Sephadex G-10, 500 µl (4x96)
CAS No.
64-17-5
supplier name
GE Healthcare UK Ltd
Icons in SDS
Company Information
company name
GE Healthcare UK Ltd
GHS Information
Signal word
WARNING!
Section 2
SECTION 2: Hazards identification
Physical state Liquid. [and Suspension.] Color solution Colorless. / Suspension. White. White to yellowish Odor Sweetish. Alcohol-like. [Slight]
Signal word
WARNING!
Hazard statements
FLAMMABLE LIQUID AND VAPOR. COMBUSTIBLE. CAUSES EYE IRRITATION. MAY CAUSE RESPIRATORY TRACT AND SKIN IRRITATION. CONTAINS MATERIAL THAT CAN CAUSE TARGET ORGAN DAMAGE.
Precautionary statements
Do not breathe vapor or mist. Use only with adequate ventilation. Do not eat, drink or smoke when using this product. Avoid contact with eyes, skin and clothing. Keep away from heat, sparks and flame. Keep container tightly closed. Wash thoroughly after handling. Routes of entry Dermal contact. Eye contact. Inhalation. Ingestion.
Potential Acute Health Effects
Eyes Irritating to eyes. Skin Moderately irritating to the skin. Inhalation Moderately irritating to the respiratory system. Ingestion No known significant effects or critical hazards.
Potential chronic health
effects Contains material that can cause target organ damage. Carcinogenicity No known significant effects or critical hazards. Mutagenicity No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects No known significant effects or critical hazards. Fertility effects No known significant effects or critical hazards. Target organs Contains material which causes damage to the following organs: kidneys. Contains material which may cause damage to the following organs: blood, the reproductive system, liver, upper respiratory tract, skin, eyes, central nervous system (CNS). Inhalation Adverse symptoms may include the following: respiratory tract irritation coughing Ingestion No specific data. Skin Adverse symptoms may include the following: irritation redness Eyes Adverse symptoms may include the following: pain or irritation watering redness
Medical Conditions Generally Aggravated by Exposure
Pre-existing disorders involving any target organs mentioned in this MSDS as being at risk may be over-exposure aggravated by over-exposure to this product. See toxicological information (Section 11)
